Loading...
One piece of the puzzle: Population pharmacokinetics of FVIII during perioperative Haemate P(®)/Humate P(®) treatment in von Willebrand disease patients
INTRODUCTION: Many patients with von Willebrand disease (VWD) are treated on demand with von Willebrand factor and factor VIII (FVIII) containing concentrates present with VWF and/or FVIII plasma levels outside set target levels. This carries a risk for bleeding and potentially for thrombosis. Devel...
Na minha lista:
| Udgivet i: | J Thromb Haemost |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7028136/ https://ncbi.nlm.nih.gov/pubmed/31557387 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jth.14652 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|